Advanced Enzyme Technologies Ltd share price logo

Advanced Enzyme Technologies Ltd (ADVENZYMES)

₹379.31.84%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Analyst Rating

based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts offering long term price targets for Advanced Enzyme Technologies Ltd. An average target of ₹470

Source: S&P Global Market Intelligence

Advanced Enzyme Technologies Ltd Share analysis

Source: S&P Global Market Intelligence

Performance

  • Day's Low

    Day's High

    ₹366.1
    ₹382.7
  • 52 Week's Low

    52 Week's High

    ₹291.1
    ₹425.15
1 Month Return-3.12 %
3 Month Return-1.94 %
1 Year Return+ 20.63 %
Previous Close₹372.45
Open₹372.00
Volume1.42L
Upper Circuit-
Lower Circuit-
Market Cap₹4,164.89Cr

Key Statistics

P/E Ratio31.22
PEG Ratio12.54
Market Cap₹4,164.89 Cr
P/B Ratio6.69
EPS11.91

Mutual Fund Holdings

Funds HoldingsPrev. 6M
HDFC Small Cap Fund-Direct Growth OptionHDFC Small Cap Fund-Direct Growth Option0.39%
ICICI Prudential ESG Exclusionary Strategy Fund Direct GrowthICICI Prudential ESG Exclusionary Strategy Fund Direct Growth2.55%
UTI MNC Fund Direct Growth OptionUTI MNC Fund Direct Growth Option1.23%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth0.54%
HDFC Multi Cap Fund Direct GrowthHDFC Multi Cap Fund Direct Growth0.12%

Company Information

Advanced Enzyme Technologies Limited AETL is the largest Indian enzyme company and is engaged in research, development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. With state-of-the-art facilities in India, Germany and USA, it has transitioned the business and transformed the sector. AETL, formerly Advanced Biochemicals Limited, was established in 1989. In 2011, the company acquired CalIndia Foods International and in 2012 it acquired Advanced Supplementary Technologies Corporation. In 2016, the company came up with an Initial Public Offer (IPO) of 4594875 Equity shares of Rs 10 each which were subscribed 82.06 times. During the financial year ended 31 March 2017, AETL acquired 1.43 crore equity shares at Rs. 35 per share of JC Biotech Private Limited (JCB) and further acquired 200,000 equity shares and 150000 equity shares of MYR 1 of AEM. On July 11 2017, AETL incorporated a wholly owned subsidiary Advanced Enzymes Europe BV. On 3 October 2017, the company acquired certain assets and liabilities of Biomedic Labs and in January 2021 it completed 'the acquisition of controlling stake of 51 in SciTech Specialities Private Limited SSPL India'. On 29 May 2021 it acquired additional 15% stake of JCB. Overall on 31 March 2021, the company had 12 subsidiaries.

Share Price: ₹379.30 per share as on 22 Jul, 2024 04:01 PM
Market Capitalisation: ₹4,164.89Cr as of today
Revenue: ₹157.82Cr as on March 2024 (Q1 24)
Net Profit: ₹29.87Cr as on March 2024 (Q1 24)
Listing date: 01 Aug, 2016
Chairperson Name: VASANT RATHI
OrganisationAdvanced Enzyme Technologies Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Advanced Enzyme Technologies Ltd

  • Advanced Enzyme Technologies Ltd to Trade Ex-Dividend - 14 Jul, 2024

    Advanced Enzyme Technologies Ltd is set to trade ex-dividend on July 18th, with a dividend payment of ₹1.10 per share to be paid on August 24th. The company has a trailing yield of approximately 1.4% on its current stock price of ₹376.40.

  • Advanced Enzyme Technologies Reports Strong FY24 Earnings - 05 Jul, 2024

    Advanced Enzyme Technologies reported strong full-year 2024 earnings with an EPS of ₹11.92 and revenue growth of 15%. The company's shares are up 8.6% from a week ago.

  • Motilal Oswal buys 1.10 crore shares in Advanced Enzyme Technologies - 20 Jun, 2024

    Motilal Oswal Financial Services Ltd bought 1.10 crore equity shares worth Rs 425.54 crore, resulting in an 8% increase in the stock price. The company's Q4FY24 revenue increased by 14%, but net profit decreased by 6%. Human nutrition business accounted for about 65% of total revenue from operations, increasing by 17% YoY. Animal nutrition business accounted for about 12% of total revenue from operations, decreasing by 10% YoY.

  • Advanced Enzyme Technologies Stake Sold by Orbimed Asia III Mauritius - 19 Jun, 2024

    Orbimed Asia III Mauritius has sold its entire 9.88% stake in Advanced Enzyme Technologies for Rs 425 crore through a block deal on the NSE, with Motilal Oswal Financial Services acquiring the shares at the same price. The biotechnology company reported a 7% decline YoY in consolidated net profit to Rs 29.90 crore in Q4 FY2024 due to high finance and depreciation costs.

Insights on Advanced Enzyme Technologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 25.94% to 36.87% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 5.50% to 5.82% in Jun 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Aarti Industries Ltd has given 44.4% return, outperforming this stock by 23.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Fine Organic Industries Ltd has given 76.2% return, outperforming this stock by 83.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 175.33 Cr → 167.31 Cr (in ₹), with an average decrease of 4.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ADVENZYMES stock has moved down by -6.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 23.01% to 12.03% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 41.77 Cr → 28.31 Cr (in ₹), with an average decrease of 32.2% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.49% to 43.02% in Jun 2024 quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹157.82Cr
↓1.94%
Net Income
₹29.87Cr
↓29.72%
Net Profit Margin
18.93%
↓28.32%
2024Y/Y Change
Revenue
₹623.87Cr
↑15.39%
Net Income
₹136.95Cr
↑31.85%
Net Profit Margin
21.95%
↑14.26%
Value in ₹ crore
2024Y/Y Change
Total Assets
₹634.30Cr
↑9.95%
Total Liabilities
₹53.82Cr
↑4.34%
Value in ₹ crore
2024Y/Y Change
Operating Cash Flow
₹55.81Cr
↑10.95%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
43.02%
-1.10
Foreign Institutions
12.03%
-47.73
Mutual Funds
5.82%
5.81
Retail Investors
36.87%
42.16
Others
2.27%
10.03

Key Indicators

Advanced Enzyme Technologies Ltd Valuation

Advanced Enzyme Technologies Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.53x)

March 23, 2020

Today (31.22x)

July 19, 2024

Industry (57.38x)

July 19, 2024

Highest (39.41x)

January 18, 2018

LowHigh

Earnings and Dividends

  • Advanced Enzyme Technologies Ltd Earnings Results

    Advanced Enzyme Technologies Ltd’s net profit fell -11.86% since last year same period to ₹28.31Cr in the Q4 2023-2024. On a quarterly growth basis, Advanced Enzyme Technologies Ltd has generated -32.22% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Advanced Enzyme Technologies Ltd Dividends May,2024

    In the quarter ending March 2024, Advanced Enzyme Technologies Ltd has declared dividend of ₹1.10 - translating a dividend yield of 2.71%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Advanced Enzyme Technologies Ltd is currently in a Bullish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Advanced Enzyme Technologies Ltd shares.

Advanced Enzyme Technologies Ltd (ADVENZYMES) share price today is ₹379.3

Advanced Enzyme Technologies Ltd is listed on NSE

Advanced Enzyme Technologies Ltd is listed on BSE

  • Today’s highest price of Advanced Enzyme Technologies Ltd is ₹382.7.
  • Today’s lowest price of Advanced Enzyme Technologies Ltd is ₹366.1.

PE Ratio of Advanced Enzyme Technologies Ltd is 31.22

PE ratio = Advanced Enzyme Technologies Ltd Market price per share / Advanced Enzyme Technologies Ltd Earnings per share

Today’s traded volume of Advanced Enzyme Technologies Ltd(ADVENZYMES) is 1.42L.

Today’s market capitalisation of Advanced Enzyme Technologies Ltd(ADVENZYMES) is ₹4164.89Cr.

Advanced Enzyme Technologies Ltd(ADVENZYMESPrice
52 Week High
₹425.15
52 Week Low
₹291.1

Advanced Enzyme Technologies Ltd(ADVENZYMES) share price is ₹379.3. It is down -10.78% from its 52 Week High price of ₹425.15

Advanced Enzyme Technologies Ltd(ADVENZYMES) share price is ₹379.3. It is up 30.30% from its 52 Week Low price of ₹291.1

Advanced Enzyme Technologies Ltd(ADVENZYMESReturns
1 Day Returns
6.85%
1 Month Returns
-3.12%
3 Month Returns
-1.94%
1 Year Returns
20.63%